Carmat, the French company behind the world’s most advanced total artificial heart, Aeson, has been ordered into liquidation by the Versailles Economic Activities Court. Once hailed as a breakthrough ...
The first 50 implants had been performed over 10 years, between 2013 (the year of Aeson® first human implant) and the end of 2023. Since early 2024, the pace of implants has accelerated sharply ...
PARIS--(BUSINESS WIRE)--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for ...
PARIS, Oct 23 (Reuters) - French artificial heart maker Carmat (ALCAR.PA), opens new tab said on Monday it had implanted seven of its Aeson devices as part of a clinical study in Paris, sending its ...
Sept 18 (Reuters) - Artificial heart maker Carmat (ALCAR.PA), opens new tab announced a capital increase of an initial 10.3 million euros ($11.5 million) on Wednesday to cover "short-term working ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback